Publications

Selected publications

  • Qi L, Iskols M, Shi D, Reddy P, Walker C, Lezgiyeva K, Voisin T, Pawlak M, Kuchroo VK, Chiu I, Ginty DD, Sharma N. 2023. A DRG genetic toolkit reveals molecular, morphological, and functional diversity of somatosensory neuron subtypes. BioArXiv.

  • Sharma N, Flaherty K, Lezgiyeva K, Wagner DE, Klein AM, Ginty DD. 2020. The emergence of transcriptional identity in somatosensory neurons. Nature. Vol. 577:392-398. Link

  • Sharma N*, Deppmann CD*, Harrington A*, Hilliare C, Chen Z-Y, Lee F, Ginty DD. 2010. Long Distance Control of Synapse Assembly by Target-derived NGF. Neuron. Vol. 67:422-434. *These authors contributed equally. Link

  • Deppmann CD*, Mihalas S*, Sharma N*, Lonze BE, Niebur E, Ginty DD. 2008. A Model for Neuronal Competition During Development. Science. Vol. 320:369-373. *These authors contributed equally. Link

  • Sharma N*, Pollina EA*, Nagy MA*, Yap E-L, DiBiase FA, Hu L, Harmin DA, Greenberg ME. 2019. Arnt2 tunes activity-dependent gene expression through NCoR2-mediated repression and Npas4-mediated activation. Neuron. Vol. 102:390-406. *These authors contributed equally. Link

  • Bloodgood BL*, Sharma N*, Browne HA, Trepman AZ, Greenberg ME. 2013. Regulation of domain-specific inhibition by the activity-dependent transcription factor NPAS4. Nature. Vol. 503:121-125. *These authors contributed equally. Link

  • Sharma N, Knight JS, Robertson ES. 2006. Conserved cell cycle regulatory properties within the amino terminal domain of the Epstein-Barr virus nuclear antigen 3C. Virology. Vol. 346: 374-384. Link

Other publications

  • Yap EL, Pettit NL, Davis CP, Nagy MA, Harmin DA, Golden E, Dagliyan O, Lin C, Rudolph S, Sharma N, Griffith EC, Harvey CD, Greenberg ME. 2021. Nature. 2021 Feb;590(7844):115-121. Link

  • Ataman B*, Boulting GL*, Harmin DA, Yang MG, Baker-Salisbury M, Yap E-L, Malik AN, Mei K, Rubin AA, Spiegel I, Durresi E, Sharma N, Hu LS, Pletikos M, Griffith EC, Partlow JN, Stevens CR, Adli M, Chahrour M, Sestan N, Walsh CA, Berezovskii VK, Livingstone MS, Greenberg ME. 2016. Evolution of Osteocrin as an activity-regulated factor in the primate brain. Nature. Vol. 539:242-247. *These authors contributed equally. Link

  • Soskis MJ, Ho HH, Bloodgood BL, Robichaux MA, Malik AN, Ataman B, Rubin AA, Zieg J, Zhang C, Shokat KM, Sharma N, Cowan CW, Greenberg ME. 2012. A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. Nature Neuroscience. Vol. 15:1645-1654. Link

  • Knight JS, Lan K, Baja BJ, Sharma N, Tsai D, Robertson ES. 2006. An E3C-TAT Peptide Inhibits B-Cell Transformation by Epstein-Barr Virus: Implications for Rational EBV Therapeutics. Virology. Vol. 354:207-214. Link

  • Knight JS, Sharma N, Robertson ES. 2005. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proceedings of the National Academy of Sciences of the USA. Vol. 102:18562-18566. Link

  • Knight JS, Sharma N, Robertson ES. 2005. SCFSkp2 Complex Targeted by Epstein Barr Virus Essential Nuclear Antigen. Molecular and Cellular Biology. Vol. 25:1749-1763. Link

  • Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. 2005. Induction of Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen by the Lytic Transactivator RTA: a Novel Mechanism for Establishment of Latency. Journal of Virology. Vol. 79:7453-7465. Link

  • Knight JS, Sharma N, Kalman DE, Robertson ES. 2004. A Cyclin-Binding Motif within the Amino-Terminal Homology Domain of EBNA3C Binds Cyclin A and Modulates Cyclin A-Dependent Kinase Activity in EBV-Infected Cells. Journal of Virology. Vol. 78:12857-12867. Link